by admin | Jan 15, 2024 | News & Opinions
By Genetic Engineering & Biotechnology News After stem cell transplantation, donated immune cells sometimes lead to graft versus host disease (GvHD). Now researchers at the Technical University of Munich (TUM) and the Universitätsklinikum Regensburg (UKR) report...
by admin | Jan 12, 2024 | News & Opinions
By Technology Networks A bioengineered “supercharged” immune cell has been designed that is particularly efficient at targeting cancer cells. At EPFL’s School of Engineering, Professor Li Tang’s Laboratory of Biomaterials for...
by admin | Jan 11, 2024 | News & Opinions
By Annalee Armstrong, Gabrielle Masson, James Waldron, Max Bayer, Ben Adams – Fierce Biotech We’re off for another day of the J.P. Morgan Healthcare Conference 2024. The flood of licensing deals and M&A may have slowed, but there’s still plenty...
by admin | Jan 9, 2024 | News & Opinions
By Eve Herold – Time – Ideas • Technology – When people hear the words “social engineering,” they usually think of the supposed nefarious designs of government or an opposing political party. These days, there’s a general sense of social upheaval...
by admin | Jan 9, 2024 | News & Opinions
by Michael Carey, PhD – UCLA Health – A study by UCLA scientists has uncovered significant insights into stem cell aging, specifically in neural stem and progenitor cells (NSPCs) in the mouse brain. The research reveals that NSPC aging is primarily...
by admin | Jan 8, 2024 | News & Opinions
By Carrie Arnold & Paul Webster – Nature Medicine – Nature Medicine asks leading researchers to name their top clinical trial for 2024, from base editing and a vaccine against HIV to artificial intelligence tools for lung cancer and patient triage....
